MC Services: experts in corporate communications and investor relations
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-5,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,qode-restaurant-1.0,tribe-no-js,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-13.0,qode-theme-bridge,bridge-child,wpb-js-composer js-comp-ver-5.4.4,vc_responsive

MC Services is an international Corporate Communications and Investor Relations firm providing Life Sciences companies high-level consultancy, targeted services and support throughout Europe and beyond

Our Services


Designing, implementing and effectively operating international Corporate Communications programs is part of our core expertise.


Our trained senior Investor Relations specialists provide a unique opportunity to have immediate access to the necessary tools, skills and networks you need in Europe, the UK and the US.


We target the appropriate audience for the unique investment proposition of your Company and help raise capital through IPOs, secondary offerings or other equity financings.  


MC Services sponsors Best Technology Award at the 2019 European Mediscience Awards

MC Services is proud to sponsor the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success, at this year’s Mediscience Awards.


The results are in, and the shortlist for the 2019 Mediscience Awards has been announced! A huge congratulation to all shortlisted companies !


The 2019 winners will be announced on Thursday 13 June at the 18th annual European MediscienceAwards.

Our News

MC Services AG
@MCServicesAGMay 17
RT @BIODeutschland: Atriva Therapeutics startet klinische Entwicklung des gegen Wirtszellen gerichteten antiviralen Medikaments ATR-002 g…
MC Services AG
@MCServicesAGMay 17
Meet @MCServicesAG in sunny #Barcelona next week at #BioEquity 2019: #invest in European #lifescience
MC Services AG
@MCServicesAGMay 16
RT @DAZheute: Die zugelassenen Arzneimittel zur Behandlung der Influenza richten sich gegen virale Strukturen. Atriva Therapeutics verfolgt…